Cardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathology

dc.contributor.authorCorbacho Alonso, Nerea
dc.contributor.authorBaldán Martín, Montserrat
dc.contributor.authorLópez, Juan Antonio
dc.contributor.authorRodríguez Sánchez, Elena
dc.contributor.authorMartínez, Paula J.
dc.contributor.authorMouriño Álvarez, Laura
dc.contributor.authorSastre Oliva, Tamara
dc.contributor.authorCabrera, Martha
dc.contributor.authorRuilope Urioste, Luis Miguel
dc.contributor.authorBarderas, María G.
dc.contributor.authorEt al.
dc.date.accessioned2021-09-21T13:50:37Z
dc.date.available2021-09-21T13:50:37Z
dc.date.issued2021
dc.description.abstractAims: Current cardiovascular (CV) risk prediction algorithms are able to quantify the individual risk of CV disease. However, CV risk in young adults is underestimated due to the high dependency of age in biomarker-based algorithms. Because oxidative stress is associated with CV disease, we sought to examine CV risk stratification in young adults based on oxidative stress to approach the discovery of new markers for early detection of pathology. Results: Young adults were stratified into (i) healthy controls, (ii) subjects with CV risk factors, and (iii) patients with a reported CV event. Plasma samples were analyzed using FASILOX, a novel approach to interrogate the dynamic thiol redox proteome. We also analyzed irreversible oxidation by targeted searches using the Uniprot database. Irreversible oxidation of cysteine (Cys) residues was greater in patients with reported CV events than in healthy subjects. These results also indicate that oxidation is progressive. Moreover, we found that glutathione reductase and glutaredoxin 1 proteins are differentially expressed between groups and are proteins involved in antioxidant response, which is in line with the impaired redox homeostasis in CV disease. Innovation: This study, for the first time, describes the oxidative stress (reversible and irreversible Cys oxidation) implication in human plasma according to CV risk stratification. Conclusion: The identification of redox targets and the quantification of protein and oxidative changes might help to better understand the role of oxidative stress in CV disease, and aid stratification for CV events beyond traditional prognostic and diagnostic markers.spa
dc.description.filiationUEMspa
dc.description.impact7.468 JCR (2021) Q1, 53/297 Biochemistry & Molecular Biologyspa
dc.description.impact1.832 SJR (2021) Q1, 42/439 Biochemistryspa
dc.description.impactNo data IDR 2021spa
dc.description.sponsorshipInstituto de Salud Carlos III PT13 / 0001/0013, PI14 / 01917, CP15 / 00129, PI17 / 01093, PI17 / 01193, FI18 / 00261, PI18 / 00995, y FI19 / 00157.spa
dc.description.sponsorshipSociedad Española de Cardiología para la Investigación Básica, Beca PRB3 (IPT17 / 0019 - ISCIII-SGEFI / FEDER)spa
dc.identifier.citationCorbacho Alonso, N., Baldán Martín, M., López, J. A., Rodríguez Sánchez, E., Martínez, P. J., Mourino Álvarez, L., Sastre Oliva, T., Cabrera, M., Calvo, E., Padial, L. R., Vázquez, J., Vivanco, F., Álvarez-Llamas, G., Ruíz-Hurtado, G., Ruilope, L. M., & Barderas, M. G. (2021). Cardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathology. Antioxidants & Redox Signaling, 35(8), 602-617. https://doi.org/10.1089/ars.2020.8254spa
dc.identifier.doi10.1089/ars.2020.8254
dc.identifier.issn1523-0864
dc.identifier.issn1557-7716
dc.identifier.urihttp://hdl.handle.net/11268/10367
dc.language.isoengspa
dc.peerreviewedSispa
dc.rights.accessRightsrestricted accessspa
dc.subject.otherEstrés oxidativospa
dc.subject.otherProteómicaspa
dc.subject.unescoEnfermedad cardiovascularspa
dc.subject.unescoAdultospa
dc.titleCardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathologyspa
dc.typejournal articlespa
dspace.entity.typePublication

Files